AIRLINE passengers may face higher ticket prices from Nov. 1 to 15 after the Civil Aeronautics Board (CAB) raised the ...

Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the publication of a ...

MPs are also expected to raise BUDI95 petrol quotas, data centre operations, road upgrades and learning loss among pupils ...

Dr. Schayowitz brings nearly 20 years of oncology drug development experience, including development leadership roles at Pfizer Oncology and Tesaro Dr. Schayowitz has led dozens of global ...

Faeth Therapeutics announced the appointment of Adam Schayowitz, Ph.D., MBA, to its Board of Directors. Dr. Schayowitz is Executive Vice President and Head of Research and Development at Zymeworks. Dr ...

The iPhone Duo is the first-generation iPhone of its kind, something we haven’t truly been able to say since the iPhone ...

These data lend support for Faeth’s multi-node strategy, with two upcoming readouts: FTH-PIK-201 topline data in second-line advanced endometrial cancer by year-end 2026 and FTH-PIK-101 interim data ...

Programs span familial and sporadic ALS, advancing Arbor’s strategic focus on the disease First CNS investigational new drug (IND) filings are anticipated in 2027 Milestone builds on clinical ...

October 19, 2026. More for You. Ukraine strikes St Petersburg with over 1,000 drones ...

Estuary Biotherapeutics, Inc., a biotechnology company developing targeted genetic medicines for serious kidney diseases, has launched with $103 million in... Read More ...

Estuary Biotherapeutics has swum out of stealth with $103 million in funding to power a pair of gene therapies into clinical ...